Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Most Read

  1. Exploring efficiencies from eTMF with Cancer Research UK
  2. Diaceutics invests in patient data to improve outcomes
  3. British universities must improve clinical trial reporting, says House of Commons
  4. Expert Insights: Moderna Therapeutics Barrels Ahead Towards Historic IPO
  5. Industry Viewpoints: Leveraging eSource in Data Management

Company A-Z

Latest Content

Exploring efficiencies from eTMF with Cancer Research UK

Creating electronic versions of documents and processes underlying clinical trials is becoming the norm. Cancer Research UK’s Stephen Nabarro walk us through its implementation of Veeva Vault eTMF two years ago, focusing on the challenges and efficiency benefit it has brought to the charity in its clinical trials work.

August’s top news stories

Biopharmaceutical firm Retrophin reported that the Phase III clinical trial of fosmetpantotenate failed to meet endpoints in pantothenate kinase-associated neurodegeneration (PKAN) patients; and MyoKardia has commenced dosing of patients in a Phase I trial of small molecule MYK-224 for the treatment of hypertrophic cardiomyopathy (HCM). Clinicaltrialsarena.com wraps up the key headlines from August 2019.

Latest News

Close
Close
Close

Go Top